vs
Arteris, Inc.(AIP)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
Arteris, Inc.的季度营收约是礼来的1.6倍($20.1M vs $12.5M),Arteris, Inc.净利率更高(-42.2% vs -1398.3%,领先1356.1%),礼来同比增速更快(434.0% vs 30.0%),Arteris, Inc.自由现金流更多($3.0M vs $-156.9M),过去两年礼来的营收复合增速更高(138.5% vs 24.7%)
Arteris公司是一家跨国科技企业,总部位于美国加利福尼亚州坎贝尔,主营片上网络(NoC)知识产权以及系统芯片(SoC)集成自动化软件的研发,产品用于各类半导体芯片与芯粒设计,客户覆盖汽车电子、人工智能、机器学习、企业计算、通信、消费电子、工业以及航空航天国防等多个领域。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
AIP vs RNA — 直观对比
营收规模更大
AIP
是对方的1.6倍
$12.5M
营收增速更快
RNA
高出404.0%
30.0%
净利率更高
AIP
高出1356.1%
-1398.3%
自由现金流更多
AIP
多$159.9M
$-156.9M
两年增速更快
RNA
近两年复合增速
24.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.1M | $12.5M |
| 净利润 | $-8.5M | $-174.4M |
| 毛利率 | 90.8% | — |
| 营业利润率 | -42.0% | -1513.5% |
| 净利率 | -42.2% | -1398.3% |
| 营收同比 | 30.0% | 434.0% |
| 净利润同比 | -3.7% | -117.0% |
| 每股收益(稀释后) | $-0.19 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AIP
RNA
| Q4 25 | $20.1M | — | ||
| Q3 25 | $17.4M | $12.5M | ||
| Q2 25 | $16.5M | $3.8M | ||
| Q1 25 | $16.5M | $1.6M | ||
| Q4 24 | $15.5M | $3.0M | ||
| Q3 24 | $14.7M | $2.3M | ||
| Q2 24 | $14.6M | $2.0M | ||
| Q1 24 | $12.9M | $3.5M |
净利润
AIP
RNA
| Q4 25 | $-8.5M | — | ||
| Q3 25 | $-9.0M | $-174.4M | ||
| Q2 25 | $-9.1M | $-157.3M | ||
| Q1 25 | $-8.1M | $-115.8M | ||
| Q4 24 | $-8.2M | $-102.3M | ||
| Q3 24 | $-7.7M | $-80.4M | ||
| Q2 24 | $-8.3M | $-70.8M | ||
| Q1 24 | $-9.4M | $-68.9M |
毛利率
AIP
RNA
| Q4 25 | 90.8% | — | ||
| Q3 25 | 89.9% | — | ||
| Q2 25 | 89.4% | — | ||
| Q1 25 | 90.8% | — | ||
| Q4 24 | 89.8% | — | ||
| Q3 24 | 90.1% | — | ||
| Q2 24 | 90.0% | — | ||
| Q1 24 | 88.7% | — |
营业利润率
AIP
RNA
| Q4 25 | -42.0% | — | ||
| Q3 25 | -50.1% | -1513.5% | ||
| Q2 25 | -50.0% | -4448.7% | ||
| Q1 25 | -46.6% | -8360.9% | ||
| Q4 24 | -45.9% | -4069.6% | ||
| Q3 24 | -53.8% | -4200.9% | ||
| Q2 24 | -51.1% | -4040.4% | ||
| Q1 24 | -70.5% | -2178.6% |
净利率
AIP
RNA
| Q4 25 | -42.2% | — | ||
| Q3 25 | -51.6% | -1398.3% | ||
| Q2 25 | -55.3% | -4089.3% | ||
| Q1 25 | -49.1% | -7360.0% | ||
| Q4 24 | -53.0% | -3439.5% | ||
| Q3 24 | -52.2% | -3441.7% | ||
| Q2 24 | -57.2% | -3461.8% | ||
| Q1 24 | -72.6% | -1943.4% |
每股收益(稀释后)
AIP
RNA
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $-0.21 | $-1.27 | ||
| Q2 25 | $-0.22 | $-1.21 | ||
| Q1 25 | $-0.20 | $-0.90 | ||
| Q4 24 | $-0.19 | $-0.80 | ||
| Q3 24 | $-0.20 | $-0.65 | ||
| Q2 24 | $-0.22 | $-0.65 | ||
| Q1 24 | $-0.25 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $33.9M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-14.6M | $1.9B |
| 总资产 | $115.0M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AIP
RNA
| Q4 25 | $33.9M | — | ||
| Q3 25 | $39.0M | $350.2M | ||
| Q2 25 | $38.0M | $243.9M | ||
| Q1 25 | $42.3M | $254.2M | ||
| Q4 24 | $43.8M | $219.9M | ||
| Q3 24 | $48.7M | $370.2M | ||
| Q2 24 | $45.8M | $575.8M | ||
| Q1 24 | $44.8M | $471.4M |
股东权益
AIP
RNA
| Q4 25 | $-14.6M | — | ||
| Q3 25 | $-11.4M | $1.9B | ||
| Q2 25 | $-7.5M | $1.2B | ||
| Q1 25 | $-4.8M | $1.3B | ||
| Q4 24 | $-1.2M | $1.4B | ||
| Q3 24 | $2.2M | $1.5B | ||
| Q2 24 | $5.3M | $1.2B | ||
| Q1 24 | $9.5M | $830.9M |
总资产
AIP
RNA
| Q4 25 | $115.0M | — | ||
| Q3 25 | $107.7M | $2.1B | ||
| Q2 25 | $106.9M | $1.4B | ||
| Q1 25 | $98.3M | $1.5B | ||
| Q4 24 | $106.1M | $1.6B | ||
| Q3 24 | $97.7M | $1.6B | ||
| Q2 24 | $96.4M | $1.3B | ||
| Q1 24 | $101.4M | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $3.0M | $-156.9M |
| 自由现金流率自由现金流/营收 | 15.1% | -1257.6% |
| 资本支出强度资本支出/营收 | 0.7% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.3M | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
AIP
RNA
| Q4 25 | $3.2M | — | ||
| Q3 25 | $3.2M | $-156.2M | ||
| Q2 25 | $-2.5M | $-199.7M | ||
| Q1 25 | $2.9M | $-124.8M | ||
| Q4 24 | $-2.6M | $-99.9M | ||
| Q3 24 | $1.1M | $-65.6M | ||
| Q2 24 | $311.0K | $-65.0M | ||
| Q1 24 | $477.0K | $-70.4M |
自由现金流
AIP
RNA
| Q4 25 | $3.0M | — | ||
| Q3 25 | $2.5M | $-156.9M | ||
| Q2 25 | $-2.8M | $-203.0M | ||
| Q1 25 | $2.7M | $-128.6M | ||
| Q4 24 | $-2.7M | $-103.8M | ||
| Q3 24 | $1.1M | $-67.3M | ||
| Q2 24 | $264.0K | $-65.5M | ||
| Q1 24 | $281.0K | $-71.3M |
自由现金流率
AIP
RNA
| Q4 25 | 15.1% | — | ||
| Q3 25 | 14.2% | -1257.6% | ||
| Q2 25 | -17.2% | -5277.1% | ||
| Q1 25 | 16.2% | -8174.3% | ||
| Q4 24 | -17.3% | -3491.0% | ||
| Q3 24 | 7.4% | -2881.8% | ||
| Q2 24 | 1.8% | -3204.6% | ||
| Q1 24 | 2.2% | -2012.3% |
资本支出强度
AIP
RNA
| Q4 25 | 0.7% | — | ||
| Q3 25 | 4.1% | 5.7% | ||
| Q2 25 | 2.2% | 86.9% | ||
| Q1 25 | 1.1% | 238.6% | ||
| Q4 24 | 0.3% | 131.7% | ||
| Q3 24 | 0.2% | 72.9% | ||
| Q2 24 | 0.3% | 26.0% | ||
| Q1 24 | 1.5% | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |
RNA
暂无分部数据